The NPKUA grant program aims to advance the science of PKU by funding the most promising research that will lead to enhanced management, new therapeutic approaches, and ultimately a cure to improve the lives of individuals with PKU. To date, we have provided over $5 million to fund over 75 grant projects. Investing in and supporting PKU research is a critical component of our work to improve our understanding of the condition, develop new treatments to optimize management and outcomes, and eventually find a cure.
Full proposals should be received no later than June 16, 2025.
Eligible applicants must have an advanced (i.e. PhD, MD, SW, GC, RD) or equivalent degree(s) and hold a fulltime position at an established clinical/academic/research institution. Both United States and international academic institutions will be considered. Investigators from centers with a history of research in metabolic diseases are strongly encouraged to apply. The average award is $50,000; however exceptional applications may be funded at higher amounts if the budget request is justified. Initial grants are awarded for one year with the potential of renewal based on progress made during the first year. In addition, the NPKUA supports some strategic projects on an on-going basis.